Qiu-Xing Yang

A novel harmine derivative, N‐(4‐(hydroxycarbamoyl)benzyl)‐1‐(4‐ methoxyphenyl)‐9H‐pyrido[3,4‐b]indole‐3‐carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects

Jinhua Tao, Yong Ling, Yanan Zhang, 2018, European journal of pharmacology.

Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities.

Yong Ling, K. Lee, S. Morris-Natschke, 2018, European journal of medicinal chemistry.

Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.

Jinhua Tao, Yong Ling, Yanan Zhang, 2018, European journal of medicinal chemistry.

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma

J. Shao, Jia Liu, Sheng-cai Wei, 2022, BMC cancer.